泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03347 泰格医药

未开盘 10-14 16:08:26

41.500

-0.800

-1.89%

最高42.600	最低41.100	成交量104.27万
今开42.400	昨收42.300	日振幅3.55%
总市值357.32亿	流通市值51.10亿	总股本8.61亿
成交额4,345万	换手率0.85%	流通股本1.23亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":41.5,"timestamp":1791965306007,"preClose":42.3,"halted":0,"volume":1042700,"delay":0,"changeRate":-0.018912529550827357,"floatShares":123124800,"shares":861000000,"eps":1.04,"marketStatus":"未开盘","change":-0.8,"latestTime":"10-14 16:08:26","open":42.4,"high":42.6,"low":41.1,"amount":43446070,"amplitude":0.035461,"askPrice":41.5,"askSize":300,"bidPrice":41.36,"bidSize":15100,"shortable":3,"etf":0,"ttmEps":0.122642,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792027800000},"marketStatusCode":0,"adr":0,"listingDate":1596729600000,"exchange":"SEHK","adjPreClose":42.3,"dividendRate":0.003551,"openAndCloseTimeList":[[1791941400000,1791950400000],[1791954000000,1791964800000]],"volumeRatio":0.9878543275843393,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":53.07,"timestamp":1791961200000,"preClose":54.32,"halted":0,"volume":6636400,"delay":0,"premium":"-33.30"}},"requestUrl":"/m/hq/s/03347","defaultTab":"news","newsList":[{"id":"2675667013","title":"股市必读：10月13日泰格医药现1笔大宗交易 机构净买入999.35万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675667013","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675667013?lang=zh_cn&edition=full","pubTime":"2026-10-14 00:54","pubTimestamp":1791910450,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，泰格医药报收于54.32元，下跌3.14%，换手率1.7%，成交量9.61万手，成交额5.23亿元。当日关注点交易信息汇总：10月13日主力资金净流入2179.85万元，占总成交额4.17%；  交易信息汇总：当日发生1笔大宗交易，机构净买入999.35万元。大宗交易10月13日泰格医药发生1笔大宗交易，机构净买入999.35万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400001152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1141","300347","BK1583","03347","BK0077","BK0028","LU1820825898.SGD","BK0216","LU1146622755.USD","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675330010","title":"今日共49只个股发生大宗交易，总成交13.68亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675330010","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675330010?lang=zh_cn&edition=full","pubTime":"2026-10-13 17:46","pubTimestamp":1791884784,"startTime":"0","endTime":"0","summary":"今日(10月13日)A股共49只个股发生大宗交易，总成交13.68亿元，其中长沙银行、雷电微力、天准科技成交额居前，成交额依次为3.05亿元、1.02亿元、9925.6万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610133894239875.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610133894239875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","LU1255011170.USD","BK1533","BK1583","LU2543165471.USD","BK1122","03347","BK1149","03308","LU1655091616.SGD","BK1576","BK1249"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674687524","title":"泰格医药（300347）披露向2026年A股限制性股票激励计划激励对象授予限制性股票的公告，10月12日股价上涨1.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674687524","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674687524?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:36","pubTimestamp":1791797805,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘，泰格医药报收于56.08元，较前一交易日上涨1.63%，最新总市值为482.86亿元。该股当日开盘55.01元，最高58.27元，最低55.0元，成交额达6.46亿元，换手率为2.01%。近日，杭州泰格医药科技股份有限公司发布《关于向2026年A股限制性股票激励计划激励对象授予限制性股票的公告》。公告显示，公司于2026年10月9日向498名激励对象授予917.477万股第二类限制性股票，授予价格为39.32元/股。股份支付费用将在2026年至2029年间摊销，预计总费用为11,790.44万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200023399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["83188","BK1147","BK1576","03347","BK1583","02846","82822","82843","02827","03130","300347","07233","LU1820825898.SGD","BK0028","02823","BK0174","BK0077","BK1610","159982","02822","83130","BK1141","03188","82823","02843","BK0216","82846","399300","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199595020","title":"泰格医药下调限制性股票激励对象至498人 并完成917.477万股授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1199595020","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199595020?lang=zh_cn&edition=full","pubTime":"2026-10-09 21:45","pubTimestamp":1791553530,"startTime":"0","endTime":"0","summary":"03347 泰格医药 10月9日公告称，公司已根据临时股东会授权，对“2026年A股限制性股票激励计划”激励对象及授予数量进行调整。因15名激励对象因离职、自愿放弃等原因不再符合条件，激励对象人数由513人调整为498人，拟授予的限制性股票总数由950万股下调至917.477万股。除本次调整外，激励计划其他条款保持不变。董事会认为，本次调整不会对公司财务状况及经营成果产生实质性影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674885495","title":"泰格医药：第六届董事会第三次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2674885495","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674885495?lang=zh_cn&edition=full","pubTime":"2026-10-09 20:21","pubTimestamp":1791548460,"startTime":"0","endTime":"0","summary":"证券日报网讯10月9日，泰格医药发布公告称，公司于2026年10月9日召开第六届董事会第三次会议，审议通过《关于调整2026年A股限制性股票激励计划激励对象名单及授予权益数量的议案》《关于向2026年A股限制性股票激励计划激励对象授予限制性股票的议案》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610093891446052.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610093891446052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03347","LU1820825898.SGD","LU1146622755.USD","BK0028","BK1583","BK1576","BK0077","BK0174","BK0216","300347","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155522619","title":"泰格医药（03347）启动2026年A股限制性股票激励 917.48万股授予498名核心员工","url":"https://stock-news.laohu8.com/highlight/detail?id=1155522619","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155522619?lang=zh_cn&edition=full","pubTime":"2026-10-09 19:55","pubTimestamp":1791546946,"startTime":"0","endTime":"0","summary":"2026年10月10日，杭州泰格医药科技股份有限公司公告称，董事会已于2026年10月9日确定并完成其2026年A股限制性股票激励计划的首次授予。授予规模与价格：本次共向498名激励对象授予917.477万股第二类限制性股票，占授予时公司总股本的1.07%，授予价格为39.32元/股，股票来源为公司回购的A股。公司表示，目前不存在法律法规规定的限制实施股权激励的情形，本次授予已获得公司股东大会及主管部门所需的全部批准与授权，相关信息已按照监管要求披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172983994","title":"泰格医药(03347)调整并授予2026年A股限制性股票：498名员工获917.477万股 激励价格39.32元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=1172983994","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172983994?lang=zh_cn&edition=full","pubTime":"2026-10-09 19:50","pubTimestamp":1791546643,"startTime":"0","endTime":"0","summary":"2026年10月9日，泰格医药董事会确定本次限制性股票激励计划的授予日，并对原定的“2026年A股限制性股票激励计划”进行调整。根据公司于深圳证券交易所网站披露的公告以及10月10日董事会薪酬与考核委员会出具的核查意见，核心信息如下：。调整后的激励对象均符合法律法规及《2026年A股限制性股票激励计划（草案）》的相关条件，主体资格合法、有效。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119445778","title":"泰格医药（03347）调整2026年A股限制性股票激励计划 取消15名激励对象合计32.523万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1119445778","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119445778?lang=zh_cn&edition=full","pubTime":"2026-10-09 19:50","pubTimestamp":1791546637,"startTime":"0","endTime":"0","summary":"2026年10月10日，杭州泰格医药科技股份有限公司公告称，董事会已于2026年10月9日审议通过《关于调整2026年A股限制性股票激励计划激励对象名单及授予权益数量的议案》，对激励对象及授予股份数量进行调整。本次调整的主要原因是激励计划拟授予名单中的15名人员因离职或自愿放弃等原因不再符合激励条件。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101227970","title":"泰格医药（03347）调整限制性股票激励计划并完成授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1101227970","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101227970?lang=zh_cn&edition=full","pubTime":"2026-10-09 19:50","pubTimestamp":1791546632,"startTime":"0","endTime":"0","summary":"2026年10月10日，泰格医药发布海外监管公告称，公司第六届董事会第三次会议已于2026年10月9日在杭州市滨江区召开，7名董事全部出席，会议程序符合相关法规及公司章程。– 授予限制性股票总量由950万股调整为917.477万股。– 董事会确认激励计划授予条件已成就，确定2026年10月9日为授予日。公司表示，除上述调整外，本次实施的股权激励计划内容与2026年第三次临时股东大会审议通过的方案一致。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674683034","title":"10月9日泰格医药现1笔大宗交易 机构净买入998.46万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674683034","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674683034?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:28","pubTimestamp":1791538127,"startTime":"0","endTime":"0","summary":"证券之星消息，10月9日泰格医药发生大宗交易，交易数据如下：大宗交易成交价格55.47元，相对当日收盘价溢价0.53%，成交18万股，成交金额998.46万元，买方营业部为机构专用，卖方营业部为广发证券股份有限公司佛山灯湖东路证券营业部。近三个月该股共发生4笔大宗交易，合计成交6960.0手，溢价成交3笔。截至2026年10月9日收盘，泰格医药报收于55.18元，下跌0.52%，换手率1.99%，成交量11.28万手，成交额6.11亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900026934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK1141","03347","BK0216","BK1576","BK0028","300347","BK0174","BK1583","LU1820825898.SGD","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674188261","title":"生物医药板块继续回调 恒生生物科技指数跌2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674188261","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674188261?lang=zh_cn&edition=full","pubTime":"2026-10-09 10:17","pubTimestamp":1791512279,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块继续回调，恒生生物科技指数跌2.31%，恒生医疗保健指数跌2.09%。个股方面，复宏汉霖（02696）跌4.84%，药明康德（02359）跌3.92%，药明合联（02268）跌3.47%，泰格医药（03347）跌3.35%，诺诚健华（09969）跌3.27%，药明生物（02269）跌3.33%，金斯瑞生物科技（01548）跌3.10%，康诺亚-B（02162）跌2.58%，百济神州（06160）跌2.44%。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993377","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0320764599.SGD","SG9999014674.SGD","BK1141","KURE","HK0000306685.HKD","IE00B0JY6N72.USD","02359","LU0359202008.SGD","SG9999002463.SGD","LU1251922891.USD","LU2242644610.SGD","BK1161","LU0348825331.USD","02268","LU2039709279.SGD","399441","LU2045819591.USD","LU0540923850.HKD","LU1880383366.USD","LU2778985437.USD","LU0463099449.HKD","LU0561508036.HKD","LU2488822045.USD","09969","LU0856984785.SGD","06160","BK4588","LU0588546209.SGD","XBI","02269","LU2125910500.SGD","BK1521","02162","02696","LU1831875114.USD","LU0516422440.USD","LU0327786744.USD","01548","LU1688375341.USD","BK4581","HK0000320264.USD","LU0128522744.USD","LU0417516902.SGD","161726","LU0181495838.USD","03347","LU0320764243.SGD","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674817638","title":"泰格医药（300347）10月8日主力资金净卖出4212.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674817638","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674817638?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:16","pubTimestamp":1791508609,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，泰格医药报收于55.47元，下跌5.02%，换手率2.19%，成交量12.39万手，成交额7.0亿元。近5日资金流向一览见下表：泰格医药融资融券信息显示，融资方面，当日融资买入4845.04万元，融资偿还5446.25万元，融资净偿还601.22万元。泰格医药主营业务：临床试验技术服务和临床试验相关服务及实验室服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900007290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK1576","BK0077","BK1141","300347","BK0174","BK1583","LU1146622755.USD","LU1820825898.SGD","03347","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673078114","title":"泰格医药最新公告：已耗资8.24亿元回购2096万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673078114","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673078114?lang=zh_cn&edition=full","pubTime":"2026-10-08 17:37","pubTimestamp":1791452265,"startTime":"0","endTime":"0","summary":"泰格医药(300347.SZ)公告称，截至2026年9月30日，公司通过集中竞价方式累计回购股份2096.35万股，占总股本的2.4347%，成交总金额为8.24亿元。回购价格区间为38.22元/股至42.78元/股，符合回购方案要求。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800022852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK1583","LU1146622755.USD","LU1820825898.SGD","BK0216","BK1141","300347","BK0174","BK1576","03347","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179335931","title":"泰格医药(03347)披露回购进展：已斥资8.24亿元回购约2096万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1179335931","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179335931?lang=zh_cn&edition=full","pubTime":"2026-10-08 17:13","pubTimestamp":1791450789,"startTime":"0","endTime":"0","summary":"2026年10月8日，杭州泰格医药科技股份有限公司在香港交易所发布海外监管公告，通报公司股份回购进展。根据公告，泰格医药于2026年5月13日及2026年6月9日分别通过董事会及股东大会审议了《回购公司股份方案》。公司表示，后续将继续根据市场情况在回购期限内实施回购计划，并按相关法规及时履行信息披露义务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673020989","title":"泰格医药(03347)：截至9月末累计回购2096.35万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673020989","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673020989?lang=zh_cn&edition=full","pubTime":"2026-10-08 17:08","pubTimestamp":1791450512,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布公告，截至2026年9月30日，公司通过股份回购专用证券账户以集中竞价交易方式回购公司股份2096.35万股，占公司目前总股本的2.4347%，占公司目前A股总股本的2.8410%。最高成交价为42.78元/股，最低成交价为38.22元/股，成交总金额为8.24亿元(不含交易费用)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504639.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02827","02843","BK0077","BK1576","07233","BK1141","BK1583","300347","BK0174","82846","BK0028","03188","82823","BK0216","82822","BK1147","159982","03130","02822","83130","82843","LU1820825898.SGD","399300","83188","03347","02823","02846","BK1610","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673027130","title":"10月8日泰格医药跌5.02%，兴全商业模式LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673027130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673027130?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:46","pubTimestamp":1791449185,"startTime":"0","endTime":"0","summary":"证券之星消息，10月8日泰格医药跌5.02%，收盘报55.47元，换手率2.19%，成交量12.39万手，成交额7.0亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共85家，其中持有数量最多的公募基金为兴证全球基金的兴全商业模式LOF。兴全商业模式LOF的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800021459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","300347","BK0174","LU1820825898.SGD","LU1146622755.USD","BK0028","BK1141","03347","BK0077","BK0216","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673497220","title":"泰格医药（300347）9月30日主力资金净买入5865.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673497220","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673497220?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:06","pubTimestamp":1791421562,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，泰格医药报收于58.4元，上涨3.42%，换手率2.52%，成交量14.24万手，成交额8.32亿元。近5日资金流向一览见下表：泰格医药融资融券信息显示，融资方面，当日融资买入8094.27万元，融资偿还8461.71万元，融资净偿还367.44万元。泰格医药主营业务：临床试验技术服务和临床试验相关服务及实验室服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800002965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","BK0174","BK0077","BK1583","BK1576","LU1146622755.USD","03347","BK0216","BK0028","300347","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174679179","title":"泰格医药更新2026年9月股份变动月报表，股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1174679179","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174679179?lang=zh_cn&edition=full","pubTime":"2026-10-07 16:38","pubTimestamp":1791362308,"startTime":"0","endTime":"0","summary":"杭州泰格医药科技股份有限公司于2026年10月7日披露了截至2026年9月30日的股份变动月报表。报告显示，公司在本月内各类别股份的已发行及注册股本均保持稳定，未出现新增发行、回购或股本注销等变动。根据月报披露，截至2026年9月30日，公司A股注册股本为737,901,250股，H股注册股本为123,124,800股，票面金额均为人民币1元，合计注册股本为人民币861,026,050元。截至本次报告期末，公司仍持有用于库藏的A股26,847,258股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673187035","title":"港股异动 | CRO概念股涨幅居前 小摩称不太担心利率上升影响板块 订单增长支撑后续业绩兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2673187035","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673187035?lang=zh_cn&edition=full","pubTime":"2026-10-06 11:55","pubTimestamp":1791258904,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0708995153.HKD","LU0181495838.USD","LU0039217434.USD","LU1242518857.USD","LU1880383366.USD","LU2778985437.USD","SG9999002562.SGD","SG9999002463.SGD","LU0456827905.SGD","LU0348825331.USD","LU0417516738.SGD","LU0456846285.SGD","LU0856984785.SGD","LU2045819591.USD","LU2476274720.SGD","LU3063872942.SGD","LU0572944931.SGD","LU1688375341.USD","IE00B0JY6N72.USD","02359","LU0540923850.HKD","LU1242518931.SGD","LU0417516902.SGD","LU1720050803.USD","LU0348767384.USD","BK1589","LU0708995583.HKD","BK1141","03347","LU0029874061.USD","LU0043850808.USD","LU0140636845.USD","KURE","LU0211977185.USD","02269","BK1610","LU1046422090.SGD","LU0823426308.USD","BK1583","LU0516423174.USD","LU0327786744.USD","LU0516422952.EUR","LU0359201612.USD","BK1576","LU0348735423.USD","LU2125910500.SGD","03759","LU0469268626.HKD","LU0128522744.USD","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673003518","title":"港股异动 | CRO概念股涨幅居前 小摩称不太担心利率上升影响板块 订单增长支撑后续业绩兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2673003518","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673003518?lang=zh_cn&edition=full","pubTime":"2026-10-06 11:55","pubTimestamp":1791258904,"startTime":"0","endTime":"0","summary":"摩根大通发布研报称，不太担心利率上升影响中国医疗健康行业。该行预期本轮加息周期将于12月再加息一次后结束，而非延续至明年的长期紧缩，因此对利率上升影响中国医疗健康估值并不太担心，并继续看好生物科技及CXO子板块。国盛证券指出，订单增长叠加ADC、GLP-1、核酸药物等新兴领域产能进入收获期，为后续CXO收入增长提供支撑，订单转化及利润兑现值得持续跟踪。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503855.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["FNCL","LU1162221912.USD","LU1974910355.USD","JPMO","TRUF","JPO","LU0029874061.USD","LU2236285917.USD","LU2417539215.USD","XLF","LU0211331839.USD","LU1261432733.SGD","FTXO","LU0039217434.USD","LU2023250504.SGD","TFNS","02269","LU0140636845.USD","LU0211328371.USD","IE00BBT3K403.USD","LU2552382215.SGD","IYG","LU0882574139.USD","LU1551013425.SGD","LU0267386448.USD","KURE","IE00BN8TJ469.HKD","LU1688375341.USD","PEX","VXUS","LU1064131342.USD","LU2023250843.SGD","BK4516","03347","KCAI","UYG","IXG","LU0256863902.USD","03759","LU2045819591.USD","IYF","LU3063872942.SGD","KBWB","XLBI","BK1583","VFH","02359","LU0348735423.USD","LU0128526141.USD","EQRR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tigermed.net","stockEarnings":[{"period":"1week","weight":-0.0851},{"period":"1month","weight":-0.0691},{"period":"3month","weight":0.0576},{"period":"6month","weight":-0.0322},{"period":"1year","weight":-0.0171},{"period":"ytd","weight":-0.0199}],"compareEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":-0.0242},{"period":"3month","weight":-0.0278},{"period":"6month","weight":-0.0706},{"period":"1year","weight":-0.0443},{"period":"ytd","weight":-0.0514}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州泰格医药科技股份有限公司是一家主要从事为新药研发提供临床试验全过程专业服务的中国公司。该公司提供服务主要包括临床试验技术服务和临床试验相关及实验室服务。临床试验技术服务提供创新药物、仿制药及医疗器械临床试验运营服务以及与临床试验直接相关的配套服务，包括临床运营、临床药理、注册与法规事务、科学事务等服务。临床试验相关及实验室服务提供在药物开发过程中的相关及实验室服务，包括数据管理及统计分析、临床试验现场管理、受试者招募、医学影像以及实验室等服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.032258},{"month":2,"riseRate":0.5,"avgChangeRate":0.003409},{"month":3,"riseRate":0.5,"avgChangeRate":-0.032695},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.051086},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.017912},{"month":6,"riseRate":0.666667,"avgChangeRate":0.042051},{"month":7,"riseRate":0.666667,"avgChangeRate":0.080461},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.061347},{"month":9,"riseRate":0.428571,"avgChangeRate":0.047335},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.038627},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.001369},{"month":12,"riseRate":0.5,"avgChangeRate":0.041242}],"exchange":"SEHK","name":"泰格医药","nameEN":"TIGERMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,03347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}